News & Alerts

News & Alerts

European Parliament amends Nano-related Text in Medical Devices Regulation
Meeting in a plenary session in Strasbourg, France, on 22 October 2013, the European Parliament voted on the Regulation on Medical Devices (2012/0266/COD). The Parliament amended some articles relating to nanomaterials used in medical devices
Brazilian Authorities agree on Surveillance of Health Effects of Nano
Brazil’s Health Surveillance Agency (ANVISA) and the country’s Council of Scientific and Technological Knowledge (CNPq) have agreed to conduct activities related to the monitoring of health effects of materials. Among those included are nanotechnologies, about which they also intend to debate the need for any regulations
NIA Member makes it easier for Users to learn about its Products
CAN GmbH, an NIA Members, has recently launched a sub-page which summarises the different products within its CANdots product range. The company focuses on the utilisation of new concepts within nanochemistry, particularly in the fields of material science, life science, and personal care
EC SCENIHR to approve Nano Opinions soon
EC's SCENIHR has revealed that it expects to approve various opinions related to nanotechnologies at its next plenary. This information was contained within the minutes from its second plenary meeting, which was held on 25 June 2013
Brazilian Bill to regulate Nanomaterials shelved; another one in the Works
The Brazilian Senate recently decided to reject a proposal to establish labelling requirements for food, pharmaceutical and cosmetic products. Bill PLS 131/2010 was first proposed in 2010
UK Environment Agency announces Creation of national Nano Business Database
The UK’s Environment Agency has revealed that it has compiled a database of the ‘[…] main users and producers of nanomaterials in the UK’. Announced in the 2012-2013 review of the agency’s Chemical Compliance Team, the work had been carried out on behalf of Defra
Magazine Article looks at NIA Presentation on Nano and Veterinary Medicines
NIA’s presentation at the Informa Research and Development in Veterinary Medicines conference has been summarised in an article. Entitled ‘What is the status of Nanotechnology for Animal Health Applications’ and presented by NIA’s Director of Advocacy, David Carlander, it ‘told delegates [….] that targeted delivery systems could reduce the amount...
OECD WPN summarises regulatory Frameworks for Nano in Foods and Medical Devices
The OECD WPN has published Regulatory Frameworks for Nanotechnology in Foods and Medical Products: Summary Results of a Survey Activity. It provides 'a snapshot of current activities across OECD WPN delegations, with respect to regulation, legislation, and government sponsored regulatory science research and other research activities relevant to...
UAE set to label Nanomaterials in Cosmetic Ingredients
A WTO notification has revealed that the UAE is to create regulations cosmetics and personal care products. Reports indicate that the draft regulation ‘[...] contains a requirement for companies to label cosmetic products containing nanomaterials’
NIA Public Briefing: Nanotechnology and the Council of Europe
The Parliamentary Assembly of the Council of Europe (PACE) has adopted a recommendation on balancing nanotechnologies benefits and risks to public health and the environment at the Assembly’s 2013 spring session held in Strasbourg, France. This recent activity in the Council of Europe has been followed by NIA, which has now written a public...
NIA EXCLUSIVE - $200 Discount on Drug Delivery & Nanotechnology 2013
NIA Members get a $200 discount on attendance for this event
NIA EXCLUSIVE - 20% Discount for Nano4Life 2013
NIA Members can receive a 20% discount on registration for this event
NIA EXCLUSIVE - 50% Discount for Nanotechnology in Medical Devices
NIA Members can receive a 50% discount on registration for this event
NIA EXCLUSIVE Members Consultation: EU-Japan Reflection Paper on Nanomedicines
The European Medicines Agency (EMA) has announced that it is running a consultation on a 'reflection paper on medicines delivered using nano-sized block copolymer micelles'. It has written the document in collaboration with the Japanese Ministry of Health, Labour and Welfare (MHLW)
Inventory of Nanomedicine Products reveals focus on fighting Cancer
An up-to-date inventory of nanomedicine products shows that there are ‘247… [of them] that are already approved or in various stages of clinical study’. According to the report ‘the most overwhelming trend observed…is the many cancer treatments under development’
NIA Members Consultation: High-level NIA Panel Appearance on the European Commission 2nd Regulatory Review Workshop
The Nanotechnology Industries Association (NIA) has been invited to present the NIA's opinion on the topic 'Why is existing regulation sufficient to ensure safe use of nanomaterials and what can industry do to generate trust?' as part of a high-level panel including European Commission officials.
Brazilian Government Authorities discuss Nanotechnology and Health
Members of several Brazilian government departments recently debated the issues surrounding nanotechnology and health surveillance. The meeting was held by the country's National Health Surveillance Agency (ANVISA) and was attended by delegates from other ministries
NIA responds to EC Call for Information on Safety of Medical Devices containing Nanomaterials
The NIA has responded to a request for information and expert input required for an investigation into the safety of nanomaterials in medical devices. The response by was made following a period of consultation it had held with its members. The call was issued by EC SCENIHR
EC Revision proposes Nano labelling for medical Devices
The EC has revised two regulations under its medical devices directive. One of the amendments states that, 'where applicable, an indication that the device incorporates or consists of nanomaterial' should be shown on the product's label. Furthermore all such devices are categorised as class III chemicals, so as to indicate a high level of concern
Chinese SFDA increases Amount of Documentation needed for Nanosilver medical Devices
China's State Food and Drug Administration (SFDA) has announced that the re-registration of medical devices containing nanosilver will require supplementary documentation. Information will be required on the 'nanomaterials' characteristics, quality control, biocompatibility, cytotoxicity, and evaluation of their genotoxicity'